Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy-Reference-Cited by-同舟云学术

Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy

Published:2005-11-08 Issue:19 Volume:112 Page:2940-2945
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Izawa Hideo¹,Murohara Toyoaki¹,Nagata Kohzo¹,Isobe Satoshi¹,Asano Hiroyuki¹,Amano Tetsuya¹,Ichihara Sahoko¹,Kato Tomoko¹,Ohshima Satoru¹,Murase Yosuke¹,Iino Shigeo¹,Obata Koji¹,Noda Akiko¹,Okumura Kenji¹,Yokota Mitsuhiro¹

Affiliation:

1. From the Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya (H.I., T.M., S. Isobe, H.A., T.K., S.O., Y.M., S. Iino, K. Okumura); Nagoya University School of Health Sciences, Nagoya (K.N., A.N.); Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya (K. Obata, M.Y.); and Department of Human Functional Genomics, Life Science Research Center, Mie University, Tsu (S. Ichihara), Japan.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference26 articles.

1. The natural history of idiopathic dilated cardiomyopathy

2. Timing of cardiac transplantation in idiopathic dilated cardiomyopathy

3. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

4. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact;Matrix Biology;2024-12

2. Circulating biomarkers of myocardial remodelling: current developments and clinical applications;Heart;2024-08-07

3. Temporal progression of replacement and interstitial fibrosis in optimally managed dilated cardiomyopathy patients: A prospective study;International Journal of Cardiology;2024-07

4. Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis;Pharmaceuticals;2024-02-20

5. Remote myocardial fibrosis predicts adverse outcome in patients with myocardial infarction on clinical cardiovascular magnetic resonance imaging;Journal of Cardiovascular Magnetic Resonance;2024